Moonlake Immunotherapeutics share price logo

Moonlake Immunotherapeutics Share Price

NASDAQ: MLTX

Mid Cap

$18.52

+4.18

(+29.11%)

as on

Moonlake Immunotherapeutics Stock Performance

as on January 10, 2026 at 2:29 am IST

  • Day's Low

    Day's High

    $14.92
    $18.65
    downward going graph

    19.44%

    Downside

    0.70%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.95
    $62.75
    downward going graph

    67.87%

    Downside

    238.82%

    Upside

    downward going graph

Moonlake Immunotherapeutics share price movements today

Previous Close
$14.34
Open
$15.20
Volume
15.6M
Day's Low - High
$14.92 - $18.65
52 Week Low - High
$5.95 - $62.75

Moonlake Immunotherapeutics Historical Returns

1 Month Return
+ 26.56 %
3 Month Return
+ 80.21 %
1 Year Return
-60.08 %
3 Year Return
+ 57.36 %
5 Year Return
0 %

Moonlake Immunotherapeutics Stock Fundamentals & Key Indicators

Check Moonlake Immunotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

-3.6024

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-227.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-54.33%

Moonlake Immunotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Moonlake Immunotherapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.0BNANA0.00%
BUY$37.5B423.25%-16.34-264.83%
BUY$52.8B171.57%1248.121.36%
BUY$120.4B95.72%33.0131.35%
BUY$84.9B59.72%19.232.13%

Stock Returns calculator for Moonlake Immunotherapeutics Stock including INR - Dollar returns

The Moonlake Immunotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Moonlake Immunotherapeutics investment value today

Current value as on today

₹44,052

Returns

₹55,948

(-55.95%)

Returns from Moonlake Immunotherapeutics Stock

₹60,009 (-60.01%)

Dollar Returns*

₹4,061 (+4.06%)

Analyst Recommendation on Moonlake Immunotherapeutics Stock

Based on 22 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 22 analysts, 81.82% of analysts recommend a 'BUY' rating for Moonlake Immunotherapeutics. Average target price of $16.96

Moonlake Immunotherapeutics Share Price Target

Get share price movements and forecasts by analysts on Moonlake Immunotherapeutics.

What analysts predicted

-9.2%DOWNSIDE

Target Price

$16.96

Current Price

$18.52

Analyzed by

22 Analysts

Target

$16.96

Moonlake Immunotherapeutics target price $16.96, a slight downside of -9.2% compared to current price of $18.52. According to 22 analysts rating.

Moonlake Immunotherapeutics Stock’s Investor Sentiment and Interest

Investment in Moonlake Immunotherapeutics Shares on INDmoney has dropped by -0.85% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-0.85% versus previous 30 day period

Search interest for Moonlake Immunotherapeutics Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-38% versus previous 30 day period

Moonlake Immunotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
0
0
-
-
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-13
-12
-15
-19
-30
-43
-49
-47
-60
-71
EBITDA
-13
-12
-15
-13
-24
-35
-48
-40
-53
-66
Interest Expense
-
-
3
3
-
-
-
0
2
3
Depreciation
0
0
0
0
0
0
1
0
0
0
Income Before Tax
-12
-11
-7
-13
-24
-36
-46
-40
-55
-70
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-10
-9
-7
-13
-24
-35
-45
-39
-55
-69
Net Profit Margin
0.00%
0.00%
-37678.97%
-69272.47%
0.00%
0.00%
-44776.15%
0.00%
0.00%
0.00%

Moonlake Immunotherapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
Gross Profit
0
0
-1
Operating Income
-65
-54
-143
EBITDA
-65
-53
-141
Interest Expense
0
-
-
Depreciation
0
0
1
Income Before Tax
-64
-43
-120
Income Tax Expense
0
0
0
Net Income
-64
-36
-118
Net Profit Margin
0.00%
0.00%
0.00%

Moonlake Immunotherapeutics Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-11
-7
-13
-24
-36
-45
-40
-56
-70
Operating Cash Flow
-9
-12
-14
-27
-25
-48
-38
-54
-44
Investing Cash Flow
-174
-
-28
-87
58
-147
56
88
88
Financing Cash Flow
-
28
50
0
0
0
73
-
0
Change in Cash
-183
133
7
-115
32
-195
91
35
44

Moonlake Immunotherapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-53
-49
-44
-121
Operating Cash Flow
-35
-55
-42
-116
Investing Cash Flow
0
-32
-25
-205
Financing Cash Flow
43
119
479
51
Change in Cash
6
31
411
-270

Global Institutional Holdings in Moonlake Immunotherapeutics

Funds
Holdings
Goldman Sachs Group Inc
2.01%
RTW INVESTMENTS, LLC
1.17%
venBio Select Advisor LLC
6.54%
T. Rowe Price Associates, Inc.
4.12%
Siren, L.L.C.
0.8%

Moonlake Immunotherapeutics News & Key Events

    Insights on Moonlake Immunotherapeutics

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 7 days, MLTX stock has moved up by 54.7%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Insmed Incorporated has given 846.1% return, outperforming this stock by 792.0%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Insmed Incorporated has given 169.7% return, outperforming this stock by 229.8%

    About Moonlake Immunotherapeutics

    moonlake immunotherapeutics ag is a clinical-stage biopharmaceutical company leveraging revolutionary nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
    OrganisationMoonlake Immunotherapeutics
    HeadquartersDorfstrasse 29, Zug, Switzerland, 6300
    CEODr. Jorge Santos da Silva Ph.D.
    E-voting on sharesClick here to vote

    Key Management of Moonlake Immunotherapeutics

    Name

    Title

    Joana Cortez

    Senior Director Legal & Compliance

    Ms. Carla Bretes

    Director of Investor Relations & External Communications

    Mr. Nicolas Mosimann Ph.D.

    General Counsel

    Tino Anthamatten

    Vice President of Marketing, Market Access & Pricing

    Luciana Marques

    Director of HR, People & Culture

    Dr. Jorge Santos da Silva Ph.D.

    Co-Founder, CEO & Director

    Dr. Kristian Reich M.D., Ph.D.

    Co-Founder & Chief Scientific Officer

    Mr. Matthias Bodenstedt

    Chief Financial Officer

    Mr. Oliver Daltrop Ph.D.

    Chief Operations Officer

    Ms. Nuala Brennan

    Chief Clinical Development Officer

    FAQs

    What is Moonlake Immunotherapeutics share price today?

    Moonlake Immunotherapeutics share price today is $18.52 as on at the close of the market. Moonlake Immunotherapeutics share today touched a day high of $18.65 and a low of $14.92.

    What is the 52 week high and 52 week low for Moonlake Immunotherapeutics share?

    Moonlake Immunotherapeutics share touched a 52 week high of $62.75 on and a 52 week low of $5.95 on . Moonlake Immunotherapeutics stock price today i.e. is closed at $18.52,which is 70.49% down from its 52 week high and 211.26% up from its 52 week low.

    What is Moonlake Immunotherapeutics's market capitalisation today?

    Moonlake Immunotherapeutics market capitalisation is $0.00T as on .

    How to invest in Moonlake Immunotherapeutics Stock (MLTX) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Moonlake Immunotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moonlake Immunotherapeutics Shares that will get you 0.0810 shares as per Moonlake Immunotherapeutics share price of $18.52 per share as on January 10, 2026 at 2:29 am IST.

    What is the minimum amount required to buy Moonlake Immunotherapeutics Stock (MLTX) from India?

    Indian investors can start investing in Moonlake Immunotherapeutics (MLTX) shares with as little as ₹90.17 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹901.70 in Moonlake Immunotherapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Moonlake Immunotherapeutics share’s latest price of $18.52 as on January 10, 2026 at 2:29 am IST, you will get 0.5400 shares of Moonlake Immunotherapeutics. Learn more about fractional shares .